Experts from BJMC & SGH begin whole genome sequencing of CHIKV
Experts at BJMC and SGH are sequencing Chikungunya virus to investigate mutations linked to severe cases and outbreaks in Pune.
Bavarian Nordic Announces Acceptance of Marketing Authorization Application for Chikungunya Vaccine in the UK for Persons Aged 12 and Older
Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has ...
5 hospitalized with cardiac and neurological symptoms after getting chikungunya vaccine
Five people have been hospitalized with cardiac and neurological symptoms after getting the chikungunya vaccine.
Pharmabiz4d
UK MHRA accepts Bavarian Nordic’s MAA for chikungunya vaccine, CHIKV VLP for persons aged 12 and older
Copenhagen, Denmark Monday, March 10, 2025, 11:00 Hrs [IST] ...
Physician's Weekly10d
Molecular Factors Driving Post-Chikungunya Chronic Joint Disease
The following is a summary of “Transcriptomic insights into early mechanisms underlying post-chikungunya chronic inflammatory ...
TMCnet13d
Valneva Receives EMA's Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®
If granted, IXCHIQ ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older Saint Herblain (France), February 28, 2025 – ...
Taiwan News13d
Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older
COPENHAGEN, Denmark, February 28, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the European Commission has granted marketing authorization in Europe for VIMKUNYA ® for active ...
WMBF News11d
5 hospitalized with cardiac and neurological symptoms after getting chikungunya vaccine
(WDTN) - Five people who recently received a vaccine that prevents a disease caused by chikungunya virus have been hospitalized. On Tuesday, the U.S. Centers for Disease Control and Prevention ...